title: A combination of ligand SAR and receptor site-directed mutagenesis reveals requirements for antagonist activity at the melanocortin-3 receptor.
authors.affiliation: Department of Medicinal Chemistry, University of Florida, Gainesville, FL 32610, USA.
authors.forename: Bettina
authors.initials: B
authors.lastname: Proneth
authors.forename: Federico P
authors.initials: FP
authors.lastname: Portillo
authors.forename: Carrie
authors.initials: C
authors.lastname: Haskell-Luevano
mesh_terms: D008024:Ligands; D016297:Mutagenesis, Site-Directed; D044104:Receptor, Melanocortin, Type 3 / Q000819:agonists* / Q000737:chemistry / Q000235:genetics; D013329:Structure-Activity Relationship
chemical_list: D008024:Ligands; D044104:Receptor, Melanocortin, Type 3